CBD Crosses the Placenta and Dilates Fetal Blood Vessels While THC Constricts Them

Using ex vivo human placental perfusion, researchers found that CBD transfers to the fetal side and dilates placental arteries via cannabinoid receptors, while THC causes constriction — revealing opposing vascular effects of the two most common cannabinoids during pregnancy.

Harhangi, M S et al.·European journal of pharmacology·2026·Preliminary Evidencepreclinical
RTHC-08320PreclinicalPreliminary Evidence2026RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
preclinical
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

CBD achieved a fetal/maternal ratio of 0.32 ± 0.23 and dilated healthy placental arteries by 36 ± 4% via CB1 and CB2 receptors, while THC induced vasoconstriction in the presence of CB1 receptor blockade — but CBD's rapid oxidation (>80% loss in 30 minutes) complicates in vivo predictions.

Key Numbers

CBD maternal concentration dropped >80% in 30 min from oxidation; fetal/maternal ratio 0.32 ± 0.23; 11 ± 4% recovered in tissue; CBD dilated arteries 36 ± 4%; dilation attenuated by AM251 and AM630; THC caused constriction with CB1 blockade

How They Did This

Ex vivo placental perfusion model using healthy term placentas with CBD quantification by LC-MS/MS, plus wire myography of chorionic plate arteries testing vascular reactivity of CBD and THC with CB1 (AM251) and CB2 (AM630) receptor antagonists.

Why This Research Matters

Many pregnant women use CBD products assuming safety, but this study shows CBD reaches the fetus and actively dilates fetal blood vessels — with unknown consequences for fetal development.

The Bigger Picture

The opposite vascular effects of CBD (dilation) and THC (constriction) on placental arteries suggest that different cannabis products may have very different effects on fetal blood supply during pregnancy.

What This Study Doesn't Tell Us

Ex vivo model may not reflect in vivo conditions; rapid CBD oxidation required adding antioxidants that wouldn't be present naturally; healthy term placentas only; single-dose experiments; vascular effects measured in isolation from other placental functions.

Questions This Raises

  • ?Does CBD's vasodilatory effect benefit or harm the fetus?
  • ?How much CBD reaches the fetus in real-world use accounting for oxidation?
  • ?Could THC-induced vasoconstriction explain cannabis-associated fetal growth restriction?

Trust & Context

Key Stat:
Evidence Grade:
Well-designed ex vivo study with receptor-specific pharmacology, but laboratory model may not accurately reflect in vivo placental transfer and oxidation dynamics.
Study Age:
Published 2026; uses current analytical methods for cannabinoid pharmacokinetics.
Original Title:
Placental transfer and vasoactivity of cannabidiol: beware of rapid oxidation.
Published In:
European journal of pharmacology, 1016, 178653 (2026)
Database ID:
RTHC-08320

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

Does CBD cross the placenta to the baby?

Yes — this study showed CBD transfers from mother to fetus across the placenta, reaching about one-third of maternal concentration, though rapid oxidation may reduce actual fetal exposure in real-world use.

How do CBD and THC differently affect placental blood flow?

CBD dilated placental blood vessels by 36% through cannabinoid receptors, while THC caused constriction — suggesting these two cannabinoids have opposite effects on blood flow to the fetus.

Read More on RethinkTHC

Cite This Study

RTHC-08320·https://rethinkthc.com/research/RTHC-08320

APA

Harhangi, M S; Höfert, L; Danser, A H J; Simons, S H P; Reiss, I K M; Baumann, S; Broekhuizen, M. (2026). Placental transfer and vasoactivity of cannabidiol: beware of rapid oxidation.. European journal of pharmacology, 1016, 178653. https://doi.org/10.1016/j.ejphar.2026.178653

MLA

Harhangi, M S, et al. "Placental transfer and vasoactivity of cannabidiol: beware of rapid oxidation.." European journal of pharmacology, 2026. https://doi.org/10.1016/j.ejphar.2026.178653

RethinkTHC

RethinkTHC Research Database. "Placental transfer and vasoactivity of cannabidiol: beware o..." RTHC-08320. Retrieved from https://rethinkthc.com/research/harhangi-2026-placental-transfer-and-vasoactivity

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.